Adarx Pharmaceuticals, A Leader In Next Generation Rna Therapeutics, Announces Oversubscribed $200 Million Series C Financing
Amount Raised
$200 Million
Round Type
Series C
San DiegoBiotechnologyHealthcareHealth CareTherapeuticsInvestors
Description
ADARx Pharmaceuticals, Inc. (“ADARx” or “the Company”), a clinical stage biotechnology company developing next generation RNA therapeutics, today announced the successful close of an oversubscribed $200 million Series C financing. The financing was led jointly by Bain Capital Life Sciences and TCGX and also included new investors Blackrock, Commodore Capital, Cormorant Asset Management, HBM Healthcare Investments, Invus, Marshall Wace, Redmile Group, T. Rowe Price Associates Inc., Venrock Healthcare Capital Partners, and Vivo Capital
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as ADARx Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
- Renibus Therapeutics raised $47M (Funding Round) on July 18, 2023.
- Qihan Biotech raised an undisclosed amount (Series B) on September 23, 2023.
- Avalyn raised $189M on September 22, 2023.
- Streamex Corp. raised $1.2M (Seed) on September 21, 2023.
- ReCode Therapeutics raised an undisclosed amount (Series B) on September 19, 2023.
Who to call at ADARx Pharmaceuticals, Inc., and when
A new round usually means ADARx Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ADARx Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ADARx Pharmaceuticals, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ADARx Pharmaceuticals, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ADARx Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ADARx Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.